• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖孕妇的药物治疗:特殊考虑。

Medications for Pregnant Women With Obesity: Special Considerations.

机构信息

Division of Maternal Fetal Medicine, Nemours Children's Hospital, Orlando, Florida.

出版信息

Clin Obstet Gynecol. 2021 Mar 1;64(1):214-225. doi: 10.1097/GRF.0000000000000584.

DOI:10.1097/GRF.0000000000000584
PMID:33306496
Abstract

Pregnant women with obesity are at increased risk of a multitude of complications of pregnancy and adverse perinatal outcomes. The risk of some of these complications, such as neural tube defects or preeclampsia, may be mitigated by some medications. Other complications, such as diabetes, venous thromboembolism, and infections, require treatment with medications. Given the changes in pharmacokinetics and pharmacodynamics during pregnancy, which is further enhanced by obesity, the optimal medication and its dose is often researched. This chapter further explores the different complications and common medications that women with obesity are likely to require.

摘要

肥胖孕妇妊娠并发症和不良围产结局的风险增加。一些并发症的风险,如神经管缺陷或子痫前期,可能通过一些药物得到缓解。其他并发症,如糖尿病、静脉血栓栓塞和感染,需要药物治疗。由于肥胖进一步增强了妊娠期间药代动力学和药效学的变化,因此经常需要研究最佳药物及其剂量。本章进一步探讨了肥胖女性可能需要的不同并发症和常见药物。

相似文献

1
Medications for Pregnant Women With Obesity: Special Considerations.肥胖孕妇的药物治疗:特殊考虑。
Clin Obstet Gynecol. 2021 Mar 1;64(1):214-225. doi: 10.1097/GRF.0000000000000584.
2
Obstetric outcomes during delivery hospitalizations among obese pregnant women in the United States.美国肥胖孕妇分娩住院期间的产科结局。
Sci Rep. 2022 Apr 27;12(1):6862. doi: 10.1038/s41598-022-10786-9.
3
Drug development research in pregnant and lactating women.妊娠期和哺乳期妇女的药物研发研究。
Am J Obstet Gynecol. 2021 Jul;225(1):33-42. doi: 10.1016/j.ajog.2021.04.227. Epub 2021 Apr 19.
4
Association between Body Mass Index and Gestational Weight Gain with Obstetric and Neonatal Complications in Pregnant Women with Gestational Diabetes.妊娠期糖尿病孕妇的体重指数和孕期体重增加与产科及新生儿并发症的关系。
Acta Med Port. 2022 Oct 3;35(10):718-728. doi: 10.20344/amp.15896.
5
Pregnancy risks associated with obesity.与肥胖相关的妊娠风险。
Obstet Gynecol Clin North Am. 2015 Jun;42(2):335-53. doi: 10.1016/j.ogc.2015.01.008.
6
Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.多囊卵巢综合征女性与孕期使用二甲双胍的女性妊娠、围产期及儿童期结局:一项全国范围内基于人群的研究。
Reprod Biol Endocrinol. 2022 Feb 7;20(1):30. doi: 10.1186/s12958-022-00905-6.
7
Cardiovascular disease and associated comorbid conditions as determinants of adverse  perinatal outcomes in pregnancy - an analysis of the results of the register of pregnant BEREG.心血管疾病及相关合并症作为妊娠围产期不良结局的决定因素——对BEREG孕妇登记册结果的分析
Ter Arkh. 2018 Feb 14;90(1):9-16. doi: 10.26442/terarkh20189019-16.
8
Risk of Pregnancy Complications in Relation to Maternal Prepregnancy Body Mass Index: Population-Based Study from Finland 2006-10.与孕产妇孕前体重指数相关的妊娠并发症风险:2006 - 2010年芬兰基于人群的研究
Paediatr Perinat Epidemiol. 2016 Jan;30(1):28-37. doi: 10.1111/ppe.12248. Epub 2015 Oct 8.
9
Psychiatric Medication Use in Pregnancy and Breastfeeding.妊娠期和哺乳期的精神药物使用。
Obstet Gynecol Clin North Am. 2021 Mar;48(1):131-149. doi: 10.1016/j.ogc.2020.11.006.
10
Maternal Pre-Pregnancy Obesity Combined With Abnormal Glucose Metabolism Further Increases Adverse Pregnancy Outcomes in Chinese Pregnant Women.母亲孕前肥胖合并糖代谢异常进一步增加中国孕妇不良妊娠结局。
Front Endocrinol (Lausanne). 2022 Jan 13;12:754406. doi: 10.3389/fendo.2021.754406. eCollection 2021.